Skip Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 13, Issue 1

2021 January-1 - 160 articles

Cover Story: The molecular diagnostic assessment of the PD-L1 test is challenging. Multiplex immunofluorescence and whole-slide digital pathological image analysis have transformed the ability to analyze clinical biomarkers. The Precision Medicine Centre of Excellence at Queen’s University Belfast, which conducts reflex testing of all non-small cell lung cancer cases for the entire population of Northern Ireland, has developed a validated multiplex immunofluorescent biomarker panel for the assessment of PD-L1. Whole-slide digital pathology fluorescent imaging, coupled with bespoke image analysis, enabled the comprehensive extraction of phenotypic data intrinsic to patient samples. The adoption of multiplex immunofluorescence and a digital pathology workflow could triage the vast majority of PD-L1 molecular diagnostic cases and augment the pathologist assessment. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (160)

  • Article
  • Open Access
5 Citations
3,482 Views
13 Pages

Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial

  • Renaud Sabatier,
  • Jean-Yves Pierga,
  • Hervé Curé,
  • Rakan Abulnaja,
  • Eric Lambaudie,
  • François-Clément Bidard,
  • Jean-Marc Extra,
  • Patrick Sfumato and
  • Anthony Gonçalves

5 January 2021

The phase II AVASTEM trial explored the impact of chemotherapy-bevacizumab combination on breast cancer stem cells in the neoadjuvant setting. We aimed to identify biological features associated with preoperative chemotherapy efficacy and prognosis b...

  • Review
  • Open Access
36 Citations
6,542 Views
17 Pages

The Network of Cytokines in Brain Metastases

  • Jawad Fares,
  • Alex Cordero,
  • Deepak Kanojia and
  • Maciej S. Lesniak

5 January 2021

Brain metastases are the most common of all intracranial tumors and a major cause of death in patients with cancer. Cytokines, including chemokines, interferons, interleukins, lymphokines, and tumor necrosis factors are key regulators in the formatio...

  • Article
  • Open Access
179 Citations
19,062 Views
16 Pages

Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries

  • Junjie Huang,
  • Anastasios Koulaouzidis,
  • Wojciech Marlicz,
  • Veeleah Lok,
  • Cedric Chu,
  • Chun Ho Ngai,
  • Lin Zhang,
  • Ping Chen,
  • Shanjuan Wang and
  • Martin C.S. Wong
  • + 6 authors

5 January 2021

This study aimed to examine the global burden, risk factors, and trends of esophageal cancer based on age, sex, and histological subtype. The data were retrieved from cancer registries database from 48 countries in the period 1980–2017. Tempora...

  • Systematic Review
  • Open Access
15 Citations
5,909 Views
17 Pages

Functional Signatures in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Sex-Based Differences in Transcriptomic Studies

  • Irene Pérez-Díez,
  • Marta R. Hidalgo,
  • Pablo Malmierca-Merlo,
  • Zoraida Andreu,
  • Sergio Romera-Giner,
  • Rosa Farràs,
  • María de la Iglesia-Vayá,
  • Mariano Provencio,
  • Atocha Romero and
  • Francisco García-García

5 January 2021

While studies have established the existence of differences in the epidemiological and clinical patterns of lung adenocarcinoma between male and female patients, we know relatively little regarding the molecular mechanisms underlying such sex-based d...

  • Review
  • Open Access
20 Citations
5,424 Views
17 Pages

NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target

  • Elissa Andraos,
  • Joséphine Dignac and
  • Fabienne Meggetto

5 January 2021

Initially discovered in anaplastic large cell lymphoma (ALCL), the ALK anaplastic lymphoma kinase is a tyrosine kinase which is affected in lymphomas by oncogenic translocations, mainly NPM-ALK. To date, chemotherapy remains a viable option in ALCL p...

  • Article
  • Open Access
10 Citations
3,969 Views
10 Pages

Use of Palliative Chemotherapy and ICU Admissions in Gastric and Esophageal Cancer Patients in the Last Phase of Life: A Nationwide Observational Study

  • Joost Besseling,
  • Jan Reitsma,
  • Judith A. Van Erkelens,
  • Maike H. J. Schepens,
  • Michiel P. C. Siroen,
  • Cathelijne M. P. Ziedses des Plantes,
  • Mark I. van Berge Henegouwen,
  • Laurens V. Beerepoot,
  • Theo Van Voorthuizen and
  • Hanneke van Laarhoven
  • + 2 authors

5 January 2021

Since intensive care unit (ICU) admission and chemotherapy use near death impair the quality of life, we studied the prevalence of both and their correlation with hospital volume in incurable gastroesophageal cancer patients as both impair the qualit...

  • Review
  • Open Access
19 Citations
5,909 Views
23 Pages

Stromal Protein-Mediated Immune Regulation in Digestive Cancers

  • Pia Gamradt,
  • Christelle De La Fouchardière and
  • Ana Hennino

5 January 2021

The stromal tumor microenvironment (TME) consists of immune cells, vascular and neural structures, cancer-associated fibroblasts (CAFs), as well as extracellular matrix (ECM), and favors immune escape mechanisms promoting the initiation and progressi...

  • Article
  • Open Access
29 Citations
6,287 Views
18 Pages

Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer

  • Leticia Díaz-Beltrán,
  • Carmen González-Olmedo,
  • Natalia Luque-Caro,
  • Caridad Díaz,
  • Ariadna Martín-Blázquez,
  • Mónica Fernández-Navarro,
  • Ana Laura Ortega-Granados,
  • Fernando Gálvez-Montosa,
  • Francisca Vicente and
  • Pedro Sánchez-Rovira
  • + 1 author

5 January 2021

Purpose: The aim of this study is to identify differential metabolomic signatures in plasma samples of distinct subtypes of breast cancer patients that could be used in clinical practice as diagnostic biomarkers for these molecular phenotypes and to...

  • Article
  • Open Access
30 Citations
7,625 Views
20 Pages

In Vivo Optical Metabolic Imaging of Long-Chain Fatty Acid Uptake in Orthotopic Models of Triple-Negative Breast Cancer

  • Megan C. Madonna,
  • Joy E. Duer,
  • Joyce V. Lee,
  • Jeremy Williams,
  • Baris Avsaroglu,
  • Caigang Zhu,
  • Riley Deutsch,
  • Roujia Wang,
  • Brian T. Crouch and
  • Nirmala Ramanujam
  • + 2 authors

5 January 2021

Targeting a tumor’s metabolic dependencies is a clinically actionable therapeutic approach; however, identifying subtypes of tumors likely to respond remains difficult. The use of lipids as a nutrient source is of particular importance, especia...

  • Article
  • Open Access
49 Citations
6,577 Views
12 Pages

Molecular Changes in Retinoblastoma beyond RB1: Findings from Next-Generation Sequencing

  • Jasmine H. Francis,
  • Allison L. Richards,
  • Diana L. Mandelker,
  • Michael F. Berger,
  • Michael F. Walsh,
  • Ira J. Dunkel,
  • Mark T. A. Donoghue and
  • David H. Abramson

5 January 2021

This investigation uses hybridization capture-based next-generation sequencing to deepen our understanding of genetics that underlie retinoblastoma. Eighty-three enucleated retinoblastoma specimens were evaluated using a MSK-IMPACT clinical next-gene...

  • Article
  • Open Access
22 Citations
5,348 Views
12 Pages

Specific and Sensitive Detection of Neuroblastoma mRNA Markers by Multiplex RT-qPCR

  • Lieke M. J. van Zogchel,
  • Lily Zappeij-Kannegieter,
  • Ahmad Javadi,
  • Marjolein Lugtigheid,
  • Nina U. Gelineau,
  • Nathalie S. M. Lak,
  • Danny A. Zwijnenburg,
  • Jan Koster,
  • Janine Stutterheim and
  • Godelieve A. M. Tytgat
  • + 1 author

5 January 2021

mRNA RT-qPCR is shown to be a very sensitive technique to detect minimal residual disease (MRD) in patients with neuroblastoma. Multiple mRNA markers are known to detect heterogeneous neuroblastoma cells in bone marrow (BM) or blood from patients. Ho...

  • Review
  • Open Access
98 Citations
16,133 Views
14 Pages

Mechanisms of Resistance to KRASG12C Inhibitors

  • Victoria Dunnett-Kane,
  • Pantelis Nicola,
  • Fiona Blackhall and
  • Colin Lindsay

5 January 2021

KRAS is one of the most common human oncogenes, but concerted efforts to produce direct inhibitors have largely failed, earning KRAS the title of “undruggable”. Recent efforts to produce subtype specific inhibitors have been more successf...

  • Review
  • Open Access
47 Citations
10,737 Views
13 Pages

The Emerging Role of Nerves and Glia in Colorectal Cancer

  • Simone L. Schonkeren,
  • Meike S. Thijssen,
  • Nathalie Vaes,
  • Werend Boesmans and
  • Veerle Melotte

5 January 2021

The role of the nervous system as a contributor in the tumor microenvironment has been recognized in different cancer types, including colorectal cancer (CRC). The gastrointestinal tract is a highly innervated organ system, which is not only innervat...

  • Article
  • Open Access
19 Citations
4,610 Views
19 Pages

Co-Overexpression of TWIST1-CSF1 Is a Common Event in Metastatic Oral Cancer and Drives Biologically Aggressive Phenotype

  • Sabrina Daniela da Silva,
  • Fabio Albuquerque Marchi,
  • Jie Su,
  • Long Yang,
  • Ludmila Valverde,
  • Jessica Hier,
  • Krikor Bijian,
  • Michael Hier,
  • Alex Mlynarek and
  • Moulay A. Alaoui-Jamali
  • + 1 author

5 January 2021

Invasive oral squamous cell carcinoma (OSCC) is often ulcerated and heavily infiltrated by pro-inflammatory cells. We conducted a genome-wide profiling of tissues from OSCC patients (early versus advanced stages) with 10 years follow-up. Co-amplifica...

  • Article
  • Open Access
47 Citations
7,760 Views
18 Pages

Immunogenomic Gene Signature of Cell-Death Associated Genes with Prognostic Implications in Lung Cancer

  • Pankaj Ahluwalia,
  • Meenakshi Ahluwalia,
  • Ashis K. Mondal,
  • Nikhil Sahajpal,
  • Vamsi Kota,
  • Mumtaz V. Rojiani,
  • Amyn M. Rojiani and
  • Ravindra Kolhe

5 January 2021

Lung cancer is one of the leading causes of death worldwide. Cell death pathways such as autophagy, apoptosis, and necrosis can provide useful clinical and immunological insights that can assist in the design of personalized therapeutics. In this stu...

  • Article
  • Open Access
17 Citations
5,181 Views
12 Pages

5 January 2021

Background: In England, patients who meet National Institute for Health and Care Excellence (NICE) guideline criteria for suspected cancer should receive a specialist assessment within 14 days. We examined how quickly bladder and kidney cancer patien...

  • Article
  • Open Access
19 Citations
4,637 Views
24 Pages

Relation of Metal-Binding Property and Selective Toxicity of 8-Hydroxyquinoline Derived Mannich Bases Targeting Multidrug Resistant Cancer Cells

  • Veronika F.S. Pape,
  • Anikó Gaál,
  • István Szatmári,
  • Nóra Kucsma,
  • Norbert Szoboszlai,
  • Christina Streli,
  • Ferenc Fülöp,
  • Éva A. Enyedy and
  • Gergely Szakács

5 January 2021

Resistance to chemotherapeutic agents is a major obstacle in cancer treatment. A recently proposed strategy is to target the collateral sensitivity of multidrug resistant (MDR) cancer. Paradoxically, the toxicity of certain metal chelating agents is...

  • Review
  • Open Access
17 Citations
9,393 Views
14 Pages

The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology

  • Clara Andradas,
  • Alexandra Truong,
  • Jacob Byrne and
  • Raelene Endersby

5 January 2021

Cannabinoids are a group of chemicals that bind to receptors in the human body and, in turn, modulate the endocannabinoid system (ECS). They can be endogenously produced, synthetic, or derived from the plant Cannabis sativa L. Research over the past...

  • Article
  • Open Access
24 Citations
5,430 Views
16 Pages

Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas

  • Valentina Condelli,
  • Giovanni Calice,
  • Alessandra Cassano,
  • Michele Basso,
  • Maria Grazia Rodriquenz,
  • Angela Zupa,
  • Francesca Maddalena,
  • Fabiana Crispo,
  • Michele Pietrafesa and
  • Matteo Landriscina
  • + 4 authors

5 January 2021

Epigenetics is involved in tumor progression and drug resistance in human colorectal carcinoma (CRC). This study addressed the hypothesis that the DNA methylation profiling may predict the clinical behavior of metastatic CRCs (mCRCs). The global meth...

  • Review
  • Open Access
33 Citations
10,186 Views
16 Pages

Ways into Understanding HIF Inhibition

  • Tina Schönberger,
  • Joachim Fandrey and
  • Katrin Prost-Fingerle

5 January 2021

Hypoxia is a key characteristic of tumor tissue. Cancer cells adapt to low oxygen by activating hypoxia-inducible factors (HIFs), ensuring their survival and continued growth despite this hostile environment. Therefore, the inhibition of HIFs and the...

  • Article
  • Open Access
50 Citations
6,629 Views
12 Pages

Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study

  • Shigeo Shimose,
  • Hideki Iwamoto,
  • Masatoshi Tanaka,
  • Takashi Niizeki,
  • Tomotake Shirono,
  • Yu Noda,
  • Naoki Kamachi,
  • Shusuke Okamura,
  • Masahito Nakano and
  • Takuji Torimura
  • + 6 authors

5 January 2021

We aimed to evaluate the impact of alternating lenvatinib (LEN) and trans-arterial therapy (AT) in patients with intermediate-stage hepatocellular carcinoma (HCC) after propensity score matching (PSM). This retrospective study enrolled 113 patients w...

  • Review
  • Open Access
51 Citations
7,745 Views
17 Pages

The p53 Pathway and Metabolism: The Tree That Hides the Forest

  • Airelle Lahalle,
  • Matthieu Lacroix,
  • Carlo De Blasio,
  • Madi Y. Cissé,
  • Laetitia K. Linares and
  • Laurent Le Cam

4 January 2021

The p53 pathway is functionally inactivated in most, if not all, human cancers. The p53 protein is a central effector of numerous stress-related molecular cascades. p53 controls a safeguard mechanism that prevents accumulation of abnormal cells and t...

  • Article
  • Open Access
23 Citations
5,114 Views
19 Pages

Ursolic Acid and Its Nanoparticles Are Potentiators of Oncolytic Measles Virotherapy against Breast Cancer Cells

  • Ching-Hsuan Liu,
  • Shu Hui Wong,
  • Chen-Jei Tai,
  • Cheng-Jeng Tai,
  • Yu-Chi Pan,
  • Hsue-Yin Hsu,
  • Christopher D. Richardson and
  • Liang-Tzung Lin

4 January 2021

Oncolytic viruses (OVs) and phytochemical ursolic acid (UA) are two efficacious therapeutic candidates in development against breast cancer, the deadliest women’s cancer worldwide. However, as single agents, OVs and UA have limited clinical eff...

  • Article
  • Open Access
6 Citations
3,121 Views
17 Pages

4 January 2021

Children treated for brain tumours often have late-appearing complications that may affect their school performance. Uneven skill profiles may help reveal late complications that can be compensated for but otherwise remain undetected. We investigated...

  • Review
  • Open Access
59 Citations
9,417 Views
15 Pages

The Evolutionary Landscape of Treatment for BRAFV600E Mutant Metastatic Colorectal Cancer

  • Gianluca Mauri,
  • Erica Bonazzina,
  • Alessio Amatu,
  • Federica Tosi,
  • Katia Bencardino,
  • Viviana Gori,
  • Daniela Massihnia,
  • Tiziana Cipani,
  • Francesco Spina and
  • Andrea Sartore-Bianchi
  • + 2 authors

4 January 2021

The BRAFV600E mutation is found in 8–10% of metastatic colorectal cancer (mCRC) patients and it is recognized as a poor prognostic factor with a median overall survival inferior to 20 months. At present, besides immune checkpoint inhibitors (CP...

  • Article
  • Open Access
7 Citations
4,014 Views
15 Pages

Loss of Tid1/DNAJA3 Co-Chaperone Promotes Progression and Recurrence of Hepatocellular Carcinoma after Surgical Resection: A Novel Model to Stratify Risk of Recurrence

  • Kuan-Yang Chen,
  • Yi-Hsiang Huang,
  • Wan-Huai Teo,
  • Ching-Wen Chang,
  • Yu-Syuan Chen,
  • Yi-Chen Yeh,
  • Chieh-Ju Lee and
  • Jeng-Fan Lo

4 January 2021

Tid1, a mitochondrial co-chaperone protein, acts as a tumor suppressor in various cancer types. However, the role of Tid1 in hepatocellular carcinoma (HCC) remains unclear. First, we found that a low endogenous Tid1 protein level was observed in poor...

  • Review
  • Open Access
95 Citations
11,200 Views
30 Pages

4 January 2021

Recent clinical successes of cancer immunotherapy using immune checkpoint inhibitors (ICIs) are rapidly changing the landscape of cancer treatment. Regardless of initial impressive clinical results though, the therapeutic benefit of ICIs appears to b...

  • Article
  • Open Access
26 Citations
5,333 Views
14 Pages

RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer

  • Caterina De Luca,
  • Francesco Pepe,
  • Antonino Iaccarino,
  • Pasquale Pisapia,
  • Luisella Righi,
  • Angela Listì,
  • Lorenza Greco,
  • Gianluca Gragnano,
  • Severo Campione and
  • Umberto Malapelle
  • + 13 authors

4 January 2021

Gene fusions represent novel predictive biomarkers for advanced non-small cell lung cancer (NSCLC). In this study, we validated a narrow NGS gene panel able to cover therapeutically-relevant gene fusions and splicing events in advanced-stage NSCLC pa...

  • Review
  • Open Access
17 Citations
5,020 Views
17 Pages

MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment

  • Federico Virga,
  • Lorena Quirico,
  • Stefania Cucinelli,
  • Massimiliano Mazzone,
  • Daniela Taverna and
  • Francesca Orso

3 January 2021

The metabolism of cancer cells is generally very different from what is found in normal counterparts. However, in a tumor mass, the continuous crosstalk and competition for nutrients and oxygen among different cells lead to metabolic alterations, not...

  • Review
  • Open Access
28 Citations
4,543 Views
13 Pages

3 January 2021

Eotaxins are proteins which belong to the group of cytokines. These small molecules are secreted by cells that are mainly involved in immune-mediated reactions in the course of allergic diseases. Eotaxins were discovered in 1994 and their main role w...

  • Review
  • Open Access
18 Citations
6,096 Views
13 Pages

Role of PUM RNA-Binding Proteins in Cancer

  • Maciej J. Smialek,
  • Erkut Ilaslan,
  • Marcin P. Sajek and
  • Jadwiga Jaruzelska

3 January 2021

Until recently, post-transcriptional gene regulation (PTGR), in contrast to transcriptional regulation, was not extensively explored in cancer, even though it seems to be highly important. PUM proteins are well described in the PTGR of several organi...

  • Review
  • Open Access
79 Citations
11,207 Views
27 Pages

Flavonoids Targeting HIF-1: Implications on Cancer Metabolism

  • Marek Samec,
  • Alena Liskova,
  • Lenka Koklesova,
  • Sandra Mersakova,
  • Jan Strnadel,
  • Karol Kajo,
  • Martin Pec,
  • Kevin Zhai,
  • Karel Smejkal and
  • Peter Kubatka
  • + 7 authors

3 January 2021

Tumor hypoxia is described as an oxygen deprivation in malignant tissue. The hypoxic condition is a consequence of an imbalance between rapidly proliferating cells and a vascularization that leads to lower oxygen levels in tumors. Hypoxia-inducible f...

  • Review
  • Open Access
217 Citations
12,323 Views
16 Pages

Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer

  • Antonio Lopez-Beltran,
  • Alessia Cimadamore,
  • Ana Blanca,
  • Francesco Massari,
  • Nuno Vau,
  • Marina Scarpelli,
  • Liang Cheng and
  • Rodolfo Montironi

3 January 2021

A number of immune checkpoint inhibitors (ICIs) have been approved as first-line therapy in case of cisplatin-ineligible patients or as second-line therapy for patients with metastatic urothelial carcinoma (mUC) of the bladder. About 30% of patients...

  • Review
  • Open Access
31 Citations
12,687 Views
21 Pages

Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?

  • Bruno Fattizzo,
  • Fabio Serpenti,
  • Wilma Barcellini and
  • Chiara Caprioli

3 January 2021

Myelodysplasias with hypocellular bone marrow (hMDS) represent about 10–15% of MDS and are defined by reduced bone marrow cellularity (i.e., <25% or an inappropriately reduced cellularity for their age in young patients). Their diagnosis is...

  • Article
  • Open Access
35 Citations
7,142 Views
13 Pages

A Randomized Trial of Physical Activity in Children and Adolescents with Cancer

  • Paul Saultier,
  • Clothilde Vallet,
  • Frédéric Sotteau,
  • Zeinab Hamidou,
  • Jean-Claude Gentet,
  • Vincent Barlogis,
  • Catherine Curtillet,
  • Arnauld Verschuur,
  • Gabriel Revon-Riviere and
  • Nicolas André
  • + 4 authors

2 January 2021

Background: to evaluate the safety and efficacy of a physical activity program (PAP) in children and adolescents with cancer. Methods: children and adolescents with cancer were randomly assigned in a 1:1 ratio to the six-month PAP (intervention group...

  • Systematic Review
  • Open Access
34 Citations
4,827 Views
15 Pages

Characterisation of Prostate Lesions Using Transrectal Shear Wave Elastography (SWE) Ultrasound Imaging: A Systematic Review

  • Thineskrishna Anbarasan,
  • Cheng Wei,
  • Jeffrey C. Bamber,
  • Richard G. Barr and
  • Ghulam Nabi

2 January 2021

Background: ultrasound-based shear wave elastography (SWE) can non-invasively assess prostate tissue stiffness. This systematic review aims to evaluate SWE for the detection of prostate cancer (PCa) and compare diagnostic estimates between studies re...

  • Article
  • Open Access
24 Citations
4,788 Views
20 Pages

In Vitro Spectroscopy-Based Profiling of Urothelial Carcinoma: A Fourier Transform Infrared and Raman Imaging Study

  • Monika Kujdowicz,
  • Wojciech Placha,
  • Brygida Mech,
  • Karolina Chrabaszcz,
  • Krzysztof Okoń and
  • Kamilla Malek

2 January 2021

Markers of bladder cancer cells remain elusive, which is a major cause of the low recognition of this malignant neoplasm and its recurrence. This implies an urgent need for additional diagnostic tools which are based on the identification of the chem...

  • Article
  • Open Access
4 Citations
3,066 Views
9 Pages

Intensity Modulated Radiotherapy with Carbon Ion Radiotherapy Boost for Acinic Cell Carcinoma of the Salivary Glands

  • Maximilian P. Schmid,
  • Thomas Held,
  • Kristin Lang,
  • Klaus Herfarth,
  • Juliane Hörner-Rieber,
  • Semi B. Harrabi,
  • Julius Moratin,
  • Christian Freudlsperger,
  • Karim Zaoui and
  • Sebastian Adeberg
  • + 1 author

2 January 2021

Aim: to report clinical outcome in patients with acinic cell carcinoma of the salivary glands treated with intensity-modulated radiotherapy (IMRT) and carbon ion radiotherapy (CIRT) boost. Materials and Methods: all patients with acinic cell carcinom...

  • Review
  • Open Access
33 Citations
10,363 Views
33 Pages

Amino Acid Transporters on the Guard of Cell Genome and Epigenome

  • Uğur Kahya,
  • Ayşe Sedef Köseer and
  • Anna Dubrovska

2 January 2021

Tumorigenesis is driven by metabolic reprogramming. Oncogenic mutations and epigenetic alterations that cause metabolic rewiring may also upregulate the reactive oxygen species (ROS). Precise regulation of the intracellular ROS levels is critical for...

  • Article
  • Open Access
10 Citations
4,752 Views
21 Pages

Mutation of the Cell Cycle Regulator p27kip1 Drives Pseudohypoxic Pheochromocytoma Development

  • Hermine Mohr,
  • Simone Ballke,
  • Nicole Bechmann,
  • Sebastian Gulde,
  • Jaber Malekzadeh-Najafabadi,
  • Mirko Peitzsch,
  • Vasilis Ntziachristos,
  • Katja Steiger,
  • Tobias Wiedemann and
  • Natalia S. Pellegata

2 January 2021

Background: Pseudohypoxic tumors activate pro-oncogenic pathways typically associated with severe hypoxia even when sufficient oxygen is present, leading to highly aggressive tumors. Prime examples are pseudohypoxic pheochromocytomas and paragangliom...

  • Review
  • Open Access
122 Citations
9,385 Views
37 Pages

Perspectives on the Role of Isoliquiritigenin in Cancer

  • Kai-Lee Wang,
  • Ying-Chun Yu and
  • Shih-Min Hsia

1 January 2021

Isoliquiritigenin (2′,4′,4-trihydroxychalcone, ISL), one of the most important bioactive compounds with a chalcone structure, is derived from licorice root. Licorice is commonly known as Glycyrrhiza, including Glycyrrhiza uralensis, Glycy...

  • Article
  • Open Access
20 Citations
3,761 Views
12 Pages

Fifteen Year Regional Center Experience in Sperm Banking for Cancer Patients: Use and Reproductive Outcomes in Survivors

  • Sara Stigliani,
  • Claudia Massarotti,
  • Caterina De Leo,
  • Elena Maccarini,
  • Fausta Sozzi,
  • Angelo Cagnacci,
  • Paola Anserini and
  • Paola Scaruffi

1 January 2021

Cancer treatments frequently impair the reproductive ability of patients by damaging spermatogenesis. International guidelines recommend semen cryopreservation to preserve the fertility of oncological adult males and pubertal boys. However, due to th...

  • Article
  • Open Access
19 Citations
3,783 Views
13 Pages

Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma

  • Catarina Nascimento,
  • Andreia Gameiro,
  • João Ferreira,
  • Jorge Correia and
  • Fernando Ferreira

1 January 2021

Vascular endothelial growth factor (VEGF-A) plays an essential role in tumor-associated angiogenesis, exerting its biological activity by binding and activating membrane receptors, as vascular endothelial growth factor receptor 1 and 2 (VEGFR-1, VEGF...

  • Article
  • Open Access
13 Citations
5,084 Views
12 Pages

Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer

  • Louisa Lepkes,
  • Mohamad Kayali,
  • Britta Blümcke,
  • Jonas Weber,
  • Malwina Suszynska,
  • Sandra Schmidt,
  • Julika Borde,
  • Katarzyna Klonowska,
  • Barbara Wappenschmidt and
  • Corinna Ernst
  • + 4 authors

1 January 2021

The identification of germline copy number variants (CNVs) by targeted next-generation sequencing (NGS) frequently relies on in silico CNV prediction tools with unknown sensitivities. We investigated the performances of four in silico CNV prediction...

  • Review
  • Open Access
5 Citations
6,174 Views
26 Pages

Dual Kinase Targeting in Leukemia

  • Luca Mologni,
  • Giovanni Marzaro,
  • Sara Redaelli and
  • Alfonso Zambon

1 January 2021

Pharmacological cancer therapy is often based on the concurrent inhibition of different survival pathways to improve treatment outcomes and to reduce the risk of relapses. While this strategy is traditionally pursued only through the co-administratio...

  • Systematic Review
  • Open Access
38 Citations
7,812 Views
14 Pages

Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

  • Hyo Jung Park,
  • Gun Ha Kim,
  • Kyung Won Kim,
  • Choong Wook Lee,
  • Shinkyo Yoon,
  • Young Kwang Chae,
  • Sree Harsha Tirumani and
  • Nikhil H. Ramaiya

1 January 2021

Despite wide recognition of iRECIST, evidence regarding the impact of iRECIST over RECIST 1.1 is lacking. We aimed to evaluate the impact of iRECIST on assessing treatment efficacy of immune checkpoint inhibitors (ICIs) over RECIST 1.1. Articles that...

  • Article
  • Open Access
12 Citations
4,060 Views
12 Pages

Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

  • Adrien Costantini,
  • Paul Takam Kamga,
  • Catherine Julie,
  • Alexandre Corjon,
  • Coraline Dumenil,
  • Jennifer Dumoulin,
  • Julia Ouaknine,
  • Violaine Giraud,
  • Thierry Chinet and
  • Etienne Giroux Leprieur
  • + 2 authors

31 December 2020

Immune checkpoint inhibitors (ICIs) are commonly used in patients with advanced non-small cell lung cancer (NSCLC). An unmet need remains for new biomarkers associated with ICIs. In this study, consecutive patients with advanced NSCLC treated with ni...

  • Article
  • Open Access
49 Citations
4,094 Views
10 Pages

Association between Growth Differentiation Factor-15 (GDF-15) Serum Levels, Anorexia and Low Muscle Mass among Cancer Patients

  • Alessio Molfino,
  • Maria Ida Amabile,
  • Giovanni Imbimbo,
  • Veronica Rizzo,
  • Federica Pediconi,
  • Carlo Catalano,
  • Alessandra Emiliani,
  • Roberta Belli,
  • Cesarina Ramaccini and
  • Maurizio Muscaritoli
  • + 2 authors

31 December 2020

The pathophysiology of cancer anorexia is complex and serum biomarkers, including growth and differentiation factor(s) (GDF), may be modulated. We explored the association(s) between GDF-15 serum levels and anorexia and, secondarily, with low muscle...

  • Article
  • Open Access
28 Citations
4,531 Views
12 Pages

Perspectives of Esophageal Cancer Survivors on Diagnosis, Treatment, and Recovery

  • Annemarie E. Bennett,
  • Linda O’Neill,
  • Deirdre Connolly,
  • Emer Guinan,
  • Lauren Boland,
  • Suzanne Doyle,
  • Jacintha O’Sullivan,
  • John V. Reynolds and
  • Juliette Hussey

31 December 2020

Esophageal cancer poses challenges to all domains of wellbeing. This qualitative study aimed to explore the experiences of esophageal cancer diagnosis, treatment, and recovery, with a view to informing the health education needs of this group. Eighte...

  • Review
  • Open Access
40 Citations
9,212 Views
27 Pages

31 December 2020

Cyclin-dependent kinase 5 (CDK5), which belongs to the protein kinase family, regulates neuronal function but is also associated with cancer development and has been proposed as a target for cancer treatment. Indeed, CDK5 has roles in cell proliferat...

of 4

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694